Word: whites
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...A.N.C.-allied Mass Democratic Movement in Johannesburg last week was most notable for its failure to include its two main rivals: < Inkatha, the Zulu-based organization led by Chief Mangosuthu Buthelezi, who heads a Pretoria-created homeland; and the Pan-Africanists, an A.N.C. splinter group that seeks to crush white "colonialists." Much of the tension stems from the A.N.C.'s insistence that it alone can negotiate on behalf of blacks...
SENIOR EDITORS: Charles P. Alexander, Jose M. Ferrer III, Russ Hoyle, Walter Isaacson, James Kelly, Stephen Koepp, Johanna McGeary, Christopher Porterfield, George Russell, Thomas A. Sancton, William E. Smith, Claudia Wallis, Jack E. White, Robert T. Zintl...
...Arthur Hochstein (Deputy Art Director); Linda Louise Freeman (Covers); Steve Conley, Jennifer Napoli, Billy Powers, Irene Ramp, Ina Saltz, John F. White, Barbara Wilhelm (Assistant Directors); Angel Ackemyer, Stefano Arata, James Elsis, Kenneth B. Smith (Designers) Production: Paul Dovell (Manager); Carri Marks Layout: John P. Dowd (Traffic); Joseph Aslaender, David Drapkin, Victoria Nightingale, Leah M. Purcell, Lisa Sampson, Nomi Silverman, Eugene Tick, Lisa C. Tremaine, Dennis Wheeler Maps and Charts: Paul J. Pugliese (Chief); Cynthia Davis, Joe Lertola, E. Noel McCoy, Nino Telak, Deborah L. Wells Administration: Carrie A. Zimmerman...
Amid all the institutional turmoil, Secretary Sullivan's decision to push out Commissioner Young has been especially inept. Sullivan has no replacement waiting, and in fact has been unable to fill many important health jobs because White House conservatives filter out nominees with proabortion views. Pro-lifers are sure to scrutinize Young's successor closely since the agency is likely to decide on approving new abortion-inducing drugs like RU 486, the pill manufactured by a French subsidiary of Hoechst...
...stop the agency's decay. Says Democratic Congressman John Dingell, chairman of the House Energy and Commerce Committee: "It was an attempt to look like they were doing something, but they aren't and they won't." In an effort to find some creative financing for the FDA, the White House has disclosed that it is considering charging user fees to companies that seek FDA approval for products. The size of the proposed service charges has ranged from an official White House suggestion of $1,500 to Young's own desire for as much as $150,000 for each product...